Here are three points:
1. The investment firm now owns a total of 230,000 shares of NuVasive, which is valued at $10.8 million.
2. Other investment companies have also been buying NuVasive shares. For example, Blackrock Institutional Trust recently bought 34,598 additional shares and now holds a total of 1.27 million NuVasive shares.
3. The company has a market cap of $2.4 billion.
More articles on devices and implants:
Stryker’s stock reaches all-time high: 5 takeaways
Smith & Nephew to introduce Navio surgical system in India: 4 key notes
SpinalCyte’s spinal disc regeneration animal studies show positive results: 3 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
